Aimei health technology co., ltd unitAFJKU.US Overview

AFJKU Earnings Table

• When is AFJKU's latest earnings report released?

  The most recent financial report for Aimei health technology co., ltd unit (AFJKU) covers the period of 2025Q1 and was published on 2025/03/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating AFJKU's short-term business performance and financial health. For the latest updates on AFJKU's earnings releases, visit this page regularly.

• Where does AFJKU fall in the P/E River chart?

  According to historical valuation range analysis, Aimei health technology co., ltd unit (AFJKU)'s current price-to-earnings (P/E) ratio is 41.56, placing it in the Reasonable zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

• How much cash does AFJKU have?

  At the end of the period, Aimei health technology co., ltd unit (AFJKU) held Total Cash and Cash Equivalents of 2.14K, accounting for 0 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

• Is AFJKU's EPS continuing to grow?

  According to the past four quarterly reports, Aimei health technology co., ltd unit (AFJKU)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 0.03. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

• What is the FCF of AFJKU?

  Aimei health technology co., ltd unit (AFJKU)'s Free Cash Flow (FCF) for the period is -224.01K, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 34.16% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

• What are the PEG ratio and PE ratio of AFJKU?

  The latest valuation data shows Aimei health technology co., ltd unit (AFJKU) has a Price-To-Earnings (PE) ratio of 41.56 and a Price/Earnings-To-Growth (PEG) ratio of -0.99. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.